Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says
Executive Summary
Last year was not the greatest performance by the agency outside of COVID-19, Richard Pops tells BIO conference.
You may also be interested in...
US FDA/Industry Thinking PDUFA VIII Could Be A Hybrid Negotiation
Virtual meetings proved successful, and could be allowed again when the next round of user fee reauthorization talks convene.
US FDA May Rethink White Oak Campus As Agency Plots New Normal For Work
A pilot project on the future of work at the FDA could lead to reduced office space requirements and improve recruitment and retention, officials say.
US FDA May Rethink White Oak Campus As Agency Plots ‘New Normal’ For Work
A pilot project on the future of work at the FDA could lead to reduced office space requirements and improve recruitment and retention, officials say.